PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 266 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $8,216,000 | -48.3% | 140,927 | -32.3% | 1.05% | -40.3% |
Q1 2022 | $15,890,000 | +26.8% | 208,197 | -0.0% | 1.76% | +27.5% |
Q4 2021 | $12,530,000 | +6.1% | 208,242 | -1.2% | 1.38% | +1.0% |
Q3 2021 | $11,809,000 | -8.3% | 210,877 | -0.6% | 1.37% | -5.0% |
Q2 2021 | $12,871,000 | +52.7% | 212,112 | +76.4% | 1.44% | +47.1% |
Q1 2021 | $8,427,000 | -2.4% | 120,232 | -16.6% | 0.98% | -15.3% |
Q4 2020 | $8,631,000 | +11.7% | 144,227 | +12.2% | 1.16% | -12.0% |
Q3 2020 | $7,726,000 | +17.2% | 128,502 | +2.3% | 1.31% | +9.2% |
Q2 2020 | $6,593,000 | +31.1% | 125,657 | -16.2% | 1.20% | +0.3% |
Q1 2020 | $5,029,000 | +8.4% | 149,992 | +46.5% | 1.20% | +66.5% |
Q4 2019 | $4,639,000 | +0.3% | 102,411 | -15.7% | 0.72% | -5.9% |
Q3 2019 | $4,624,000 | -3.0% | 121,466 | +10.8% | 0.76% | +3.7% |
Q2 2019 | $4,767,000 | +39.3% | 109,611 | +21.9% | 0.74% | +39.8% |
Q1 2019 | $3,422,000 | -48.6% | 89,921 | -41.9% | 0.53% | -41.0% |
Q4 2018 | $6,657,000 | -27.2% | 154,736 | -16.8% | 0.90% | +8.0% |
Q3 2018 | $9,140,000 | +19.0% | 185,906 | -22.4% | 0.83% | +17.3% |
Q2 2018 | $7,681,000 | -19.6% | 239,641 | -21.9% | 0.71% | -24.6% |
Q1 2018 | $9,555,000 | -49.0% | 306,786 | -25.3% | 0.94% | -29.2% |
Q4 2017 | $18,742,000 | +27.7% | 410,561 | +5.1% | 1.32% | +37.2% |
Q3 2017 | $14,671,000 | – | 390,685 | – | 0.97% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tamarack Advisers, LP | 360,000 | $21,845,000 | 6.19% |
Gagnon Advisors, LLC | 213,217 | $12,938,000 | 4.92% |
GAGNON SECURITIES LLC | 499,333 | $30,300,000 | 4.30% |
Spyglass Capital Management LLC | 2,117,673 | $128,500,000 | 2.86% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 646,530 | $39,231,000 | 2.30% |
Paulson & Co. | 1,273,161 | $77,255,000 | 1.85% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 212,112 | $12,871,000 | 1.44% |
Tygh Capital Management, Inc. | 152,332 | $9,244,000 | 1.26% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,147,000 | $69,600,000 | 1.24% |
Rock Springs Capital Management LP | 1,025,000 | $62,197,000 | 1.23% |